Fidelity Investments
AURA icon

Fidelity Investments’s Aura Biosciences AURA Stock Holding History

Fidelity Investments’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Sell
2,894
-5,244
-64% -$30.1K ﹤0.01% 4529
2025
Q4 		$44.4K Buy
8,138
+4,671
+135% +$27.7K ﹤0.01% 4170
2025
Q3 		$21.4K Buy
3,467
+1,925
+125% +$12.6K ﹤0.01% 4327
2025
Q2 		$9.65K Sell
1,542
-28,102
-95% -$164K ﹤0.01% 4538
2025
Q1 		$174K Sell
29,644
-1,901
-6% -$14.4K ﹤0.01% 3304
2024
Q4 		$259K Sell
31,545
-69,672
-69% -$656K ﹤0.01% 3164
2024
Q3 		$902K Sell
101,217
-129,234
-56% -$1.11M ﹤0.01% 2631
2024
Q2 		$1.74M Sell
230,451
-64,203
-22% -$470K ﹤0.01% 2385
2024
Q1 		$2.31M Sell
294,654
-62,381
-17% -$517K ﹤0.01% 2296
2023
Q4 		$3.16M Sell
357,035
-1,526
-0.4% -$12.9K ﹤0.01% 2199
2023
Q3 		$3.22M Sell
358,561
-75
-0% -$807 ﹤0.01% 2162
2023
Q2 		$4.43M Buy
358,636
+1,789
+0.5% +$19.1K ﹤0.01% 2101
2023
Q1 		$3.31M Sell
356,847
-371,550
-51% -$3.86M ﹤0.01% 2230
2022
Q4 		$7.65M Buy
728,397
+124,636
+21% +$1.59M ﹤0.01% 1996
2022
Q3 		$10.9M Buy
603,761
+290
+0% +$4.39K ﹤0.01% 1859
2022
Q2 		$8.55M Buy
603,471
+109,362
+22% +$1.81M ﹤0.01% 2033
2022
Q1 		$10.9M Buy
494,109
+22,809
+5% +$435K ﹤0.01% 2090
2021
Q4 		$8M Buy
+471,300
New +$8.42M ﹤0.01% 2202

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments's AURA Position: Q1 2026 in Review

Fidelity Investments reduced its Aura Biosciences (AURA) stake by 64% in Q1 2026, selling an estimated $30.1K and leaving 2,894 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4529.

Fidelity Investments first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $10.9M in Q3 2022. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Fidelity Investments held 2,894 shares of Aura Biosciences worth $19.4K as of Q1 2026.
  • Fidelity Investments sold 5,244 Aura Biosciences shares in Q1 2026, an estimated $30.1K.
  • Aura Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4529 holding.
  • Fidelity Investments first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Fidelity Investments's Aura Biosciences position peaked at $10.9M in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.